Revvity | PKI - 净收入



金融业
股票价格
USD
资产
USD 12B
现金及等价物
USD 860.32M
销售成本
USD 323.46M
流动资产
USD 2.13B
流动负债
USD 1.24B
债务
USD 3.4B
股息收益率
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
员工
11K
EPS每股收益
USD 1.06
股本和储备
USD 7.25B
销售毛利
USD 387.66M
债务利息支出
USD 24.72M
利息收入
USD 5.75M
贷款资金
USD 2.63B
市值
USD 14.05B
净收入
USD 40.72M
营业费用
USD 628.35M
营业利润
USD 82.77M
普通股股本
USD 111.8M
PE价格收益
30.79
税前利润
USD 91.56M
销售收入
USD 711M
销售和管理费用
USD 253.88M
股票
USD 387.51M
贸易债权人
USD 169.68M
应收帐款人
USD 691.38M


净收入 更改 日
Agilent USD 339M 34M 2026-03
Align Technology USD 112.77M 22.99M 2026-03
Bio Techne USD 51.05M 13.04M 2026-03
Bio-Rad Laboratories USD 720M 1.06B 2025-12
Bruker USD 3.5M 22.5M 2026-03
Celltrion KRW 8.88B 322.47B 2025-12
Charles River Laboratories USD -14.84M 261.71M 2026-03
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Danaher USD 1.03B 168M 2026-03
Dentsply International USD -10M 136M 2026-03
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 7.51B 1.68B 2026-03
Edwards Lifesciences USD 380.7M 289.5M 2026-03
Illumina USD 134M 200M 2026-03
Intuitive Surgical USD 821.5M 26.7M 2026-03
IQVIA Holdings USD 274M 240M 2026-03
Kangmei Pharma CNY -16.56M 12.74M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Laboratory Of America USD 277.8M 113.1M 2026-03
Malin Corporation EUR -1.1M 2.2M 2023-12
Medical Developments International AUD -226K 121K 2025-12
Mesa Laboratories USD -1.68M 5.1M 2024-12
Mettler Toledo International USD 169.45M 116.31M 2026-03
Myriad Genetics USD -7.9M 19.5M 2025-12
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
OraSure Technologies USD -19.29M 5.57M 2025-12
Organigram Holdings CAD -921K 20.89M 2026-03
Ovoca Bio EUR -765K 4.89M 2025-06
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Pharma Mar EUR 1.53M 58.13M 2026-03
Qiagen NV USD 107.83M 22.21M 2025-12
Quest Diagnostics USD 251M 6M 2026-03
Quidel USD -91.8M 38.9M 2026-03
Repligen USD 8.33M 4.95M 2026-03
Revvity USD 40.72M 57.65M 2026-03
Sartorius EUR 56.2M 37M 2026-03
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Thermo Fisher Scientific USD 1.65B 313M 2026-03
Tilray USD -44.93M 44.61M 2025-09
Waters USD -72M 297.21M 2026-03
Zealand Pharma A/S -379.12M 25.12M 2025-12
Zz Pientze Pharmaceu CNY 743.48M 56.45M 2026-03